- Guselkumab, sold
under the
brand name
Tremfya, is a
monoclonal antibody against interleukin-23 used for the
treatment of
plaque psoriasis,
psoriatic arthritis...
- hypertension.
Immunology therapies Remicade Simponi Simponi Aria
Stelara Tremfya Infectious diseases therapies Edurant Intelence Prezcobix Symtuza Janssen...
-
Sirturo Sporanox Spravato Stelara Symtuza Talvey Tecvayli Terazol Topamax Tremfya Ultracet Ultram Vermox Xarelto Yondelis Zytiga Opsumit Tracleer Zavesca...
-
Gosuranemab mab
humanized tau
protein progressive supranuclear palsy Guselkumab Tremfya mab
human IL-23 Y
psoriasis Ianalumab mab
human BAFF-R
autoimmune hepatitis...
-
platform drugs received US
marketing approval.
Guselkumab (brand name
Tremfya),
which was
developed and is
being commercialized by
Janssen Biotech a...
-
intravenous fully human TNF
Rheumatoid arthritis 125433 Link
guselkumab Tremfya Janssen Biotech 7/13/17
subcutaneous fully human IL23
Plaque psoriasis...
- Propecia, Relenza, Climara, Proscar, Invega, Lunesta, Latisse, Entresto,
Tremfya, Brineura, Privigen, Zykadia, Tecfidera, Brukinsa, Zolgensma, Xpovio, and...
